Eventide Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Eventide Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-206,000	Closed	-$23.8M	–	180
2020 Q4	$23.8M	Sell	206,000 -230,000	-53%	-$25.8M	0.36%	84
2020 Q3	$42.4M	Hold	436,000	–	–	0.83%	44
2020 Q2	$53.5M	Hold	436,000	–	–	1.16%	28
2020 Q1	$38.2M	Hold	436,000	–	–	1.24%	31
2019 Q4	$45.6M	Buy	436,000 +261,000	+149%	+$29.3M	1.28%	30
2019 Q3	$20.1M	Hold	175,000	–	–	0.67%	55
2019 Q2	$30.2M	Buy	175,000 +81,994	+88%	+$14.2M	0.92%	37
2019 Q1	$15.7M	Buy	93,006 +29,506	+46%	+$4.39M	0.54%	65
2018 Q4	$6.18M	Hold	63,500	–	–	0.27%	83
2018 Q3	$11M	Hold	63,500	–	–	0.4%	72
2018 Q2	$8.86M	Hold	63,500	–	–	0.37%	75
2018 Q1	$7.16M	Hold	63,500	–	–	0.34%	81
2017 Q4	$8.38M	Hold	63,500	–	–	0.44%	64
2017 Q3	$6.45M	Hold	63,500	–	–	0.37%	71
2017 Q2	$6.37M	Hold	63,500	–	–	0.4%	65
2017 Q1	$7.68M	Hold	63,500	–	–	0.51%	56
2016 Q4	$7.1M	Hold	63,500	–	–	0.46%	61
2016 Q3	$8.43M	Sell	63,500 -10,000	-14%	-$956K	0.51%	54
2016 Q2	$6.73M	Hold	73,500	–	–	0.41%	65
2016 Q1	$5.3M	Hold	73,500	–	–	0.3%	73
2015 Q4	$5.1M	Buy	73,500 +4,800	+7%	+$391K	0.26%	87
2015 Q3	$6.28M	Buy	68,700 +32,600	+90%	+$3.62M	0.36%	66
2015 Q2	$4.43M	Buy	36,100 +2,600	+8%	+$295K	0.24%	80
2015 Q1	$3.05M	Buy	33,500 +8,500	+34%	+$690K	0.23%	85
2014 Q4	$1.69M	Hold	25,000	–	–	0.18%	84
2014 Q3	$2.02M	Hold	25,000	–	–	0.28%	70
2014 Q2	$2.68M	Buy	+25,000	New	+$1.74M	0.36%	68

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eventide Asset Management's GWPH Position: Q1 2021 in Review

Eventide Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 206,000 shares — an estimated $23.8M sold.

Eventide Asset Management first reported a position in GWPH in Q2 2014 and held it in 27 quarters. The position peaked at $53.5M in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Eventide Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Eventide Asset Management sold 206,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $23.8M.
Eventide Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 27 quarters.
Eventide Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $53.5M in Q2 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.